Atomic AI
Atomic AI is seeking a Data Scientist on the Machine Learning team to advance RNA-targeted preclinical drug discovery by extracting insights from high-throughput RNA–small molecule datasets. The role leverages the company’s R&D platform to develop in silico screening pipelines and inform ML model development and experimental data acquisition. The position works closely with wetlab teams and contributes to the design of computational tools and predictive models to support small-molecule discovery.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Atomic AI is a biotechnology company focused on RNA drug discovery and RNA-centric medicines. It leverages machine learning and structural biology, including its ATOM-1 foundation model for predicting RNA 3D structures, to unlock targets for RNA-targeted small molecules and RNA-based therapeutics. Its proprietary R&D platform combines advanced deep learning with in-house wet-lab assays to accelerate discovery and development in the RNA therapeutics space.
Atomic AI: Why NuScale Is the Only Option
1 week ago
Vivox AI Secures £1.3M to Scale Regulator-Ready Atomic AI Agents for Financial Crime Compliance
1 week ago
The Atomic AI Surge: Oklo Inc. Shares Skyrocket as Meta Partnership Ignites a Nuclear Sector Breakout
Jan 9, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Atomic AI.
Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases
Jan 25, 2023
Director, Computational Chemistry, Modeling & Informatics
MSD
Research Advisor, Computational Chemistry
Eli Lilly and Company
Scientist / Senior Scientist in Cheminformatics
Roche
Principal Scientist, Computational Chemistry
Eikon Therapeutics
Computational Chemist
Ashby
Head of Computational Chemistry
General Proximity